CGRP-ANTAGONISTENVERBINDUNGEN

Patent europeic · EP3983416 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3983416
Numer da la dumonda
EP20734276
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
12-06-2020
Publitgà
20-04-2022
Concedì
03-09-2025
La protecziun finescha il pli tard
11-06-2040
Proxima taxa annuala scadenta
30-06-2026
Classas IPC
C07D 498/22 (2006.01)
A61K 31/438 (2006.01)
A61P 25/06 (2006.01)
Prioritad
GB 201908420 12.06.2019
Dumonda PCT
PCT/GB2020/051428 12.06.2020
Publicaziun PCT
WO2020/249969 17.12.2020
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 15-07-2026

    Midada

    Published in Swissreg on 15.07.2026

  2. 03-09-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.09.2025

Partidas

Possessur

Nxera Pharma UK Limited

Granta Park Great Abington, Cambridge, Cambridgeshire CB21 6DG, GB

Inventur

BROWN, Giles Albert

Cambridge CB21 6DG, GB

CONGREVE, Miles Stuart

Cambridge CB21 6DG, GB

WATSON, Stephen Paul

Cambridge CB21 6DG, GB

CANSFIELD, Julie

Cambridge CB21 6DG, GB

O'BRIEN, Michael Alistair

Cambridge CB21 6DG, GB

DEFLORIAN, Francesca

Cambridge CB21 6DG, GB

OTT, Gregory R.

North Wales, Pennsylvania 19454, US

SWAIN, Nigel Alan

Cambridge CB21 6DG, GB

CANSFIELD, Andrew David

Cambridge CB21 6DG, GB

CHRISTOPHER, John Andrew

Cambridge CB21 6DG, GB

BORTOLATO, Andrea

Cambridge CB21 6DG, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.